(MENAFN- GlobeNewsWire - Nasdaq) New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Artificial Intelligence in Diabetes Management Market Research Report by Device, by technique - Global Forecast to 2025 - Cumulative Impact of COVID-19" - [...]
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from USD 347.73 Million in 2020 to USD 1,275.42 Million by the end of 2025.
2. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from EUR 304.90 Million in 2020 to EUR 1,118.31 Million by the end of 2025.
3. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from GBP 271.05 Million in 2020 to GBP 994.18 Million by the end of 2025.
4. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from JPY 37,112.36 Million in 2020 to JPY 136,120.28 Million by the end of 2025.
5. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from AUD 504.96 Million in 2020 to AUD 1,852.08 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Artificial Intelligence in Diabetes Management to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Device, the Artificial Intelligence in Diabetes Management Market studied across Diagnostic Devices, Glucose Monitoring Devices, and Insulin Delivery Devices.
Based on technique, the Artificial Intelligence in Diabetes Management Market studied across Case-based Reasoning and Intelligent Data Analysis.
Based on Geography, the Artificial Intelligence in Diabetes Management Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence in Diabetes Management Market including Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, Diabnext, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann-La Roche Ltd, HCL Technologies Limited, IBM Corporation, Karger AG, Medtronic PLC, Nasdaq Inc, Novartis AG, Novo Nordisk A/S, Sanofi SA, Virta Health Corp., Vodafone Group PLC, Whisk, and xbird GmbH.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Diabetes Management Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R & D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Artificial Intelligence in Diabetes Management Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Diabetes Management Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Diabetes Management Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Diabetes Management Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Diabetes Management Market?
6. What are the modes and strategic moves considered suitable for entering the Global Artificial Intelligence in Diabetes Management Market?
Read the full report: [...]
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Clare: US: (339)-368-6001
Intl: +1 339-368-6001
MENAFN18012021004107003653ID1101451760
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.